These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8039478)
41. Selective suppression of hippocampal region hyperexcitability related to seizure susceptibility in epileptic El mice by the GABA-transporter inhibitor tiagabine. Fueta Y; Schwarz W; Ohno K; Endo Y; Mita T Brain Res; 2002 Aug; 947(2):212-7. PubMed ID: 12176163 [TBL] [Abstract][Full Text] [Related]
42. Tiagabine and non-convulsive status epilepticus. Schapel G; Chadwick D Seizure; 1996 Jun; 5(2):153-6. PubMed ID: 8795133 [TBL] [Abstract][Full Text] [Related]
46. The effect of tiagabine on spasticity in children with intractable epilepsy: a pilot study. Holden KR; Titus MO Pediatr Neurol; 1999 Oct; 21(4):728-30. PubMed ID: 10580885 [TBL] [Abstract][Full Text] [Related]
47. Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers. Sofuoglu M; Mouratidis M; Yoo S; Culligan K; Kosten T Psychopharmacology (Berl); 2005 Sep; 181(3):504-10. PubMed ID: 15983800 [TBL] [Abstract][Full Text] [Related]
49. Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception. Laughlin TM; Tram KV; Wilcox GL; Birnbaum AK J Pharmacol Exp Ther; 2002 Sep; 302(3):1168-75. PubMed ID: 12183677 [TBL] [Abstract][Full Text] [Related]
50. Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice. Łuszczki J; Swiader M; Czuczwar M; Kiś J; Czuczwar SJ Pharmacol Biochem Behav; 2003 May; 75(2):319-27. PubMed ID: 12873622 [TBL] [Abstract][Full Text] [Related]
51. Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine. Sills GJ Epileptic Disord; 2003 Mar; 5(1):51-6. PubMed ID: 12773297 [TBL] [Abstract][Full Text] [Related]
52. Effects of valproate, vigabatrin and tiagabine on GABA uptake into human astrocytes cultured from foetal and adult brain tissue. Fraser CM; Sills GJ; Butler E; Thompson GG; Lindsay K; Duncan R; Howatson A; Brodie MJ Epileptic Disord; 1999 Sep; 1(3):153-7. PubMed ID: 10937147 [TBL] [Abstract][Full Text] [Related]
53. Different effects of GABAergic anticonvulsants on 4-aminopyridine-induced spontaneous GABAergic hyperpolarizations of hippocampal pyramidal cells--implication for their potency in migraine therapy. Leniger T; Wiemann M; Bingmann D; Hufnagel A; Bonnet U Cephalalgia; 2000 Jul; 20(6):533-7. PubMed ID: 11075835 [TBL] [Abstract][Full Text] [Related]
55. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy. Kälviäinen R J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():63-7. PubMed ID: 10030435 [TBL] [Abstract][Full Text] [Related]
57. The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate. Andersen KE; Braestrup C; Grønwald FC; Jørgensen AS; Nielsen EB; Sonnewald U; Sørensen PO; Suzdak PD; Knutsen LJ J Med Chem; 1993 Jun; 36(12):1716-25. PubMed ID: 8510100 [TBL] [Abstract][Full Text] [Related]